Alexandra Balcom - Dec 17, 2024 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role
Chief Financial Officer
Signature
/s/ Nathan N. McConarty, attorney-in-fact
Stock symbol
NUVL
Transactions as of
Dec 17, 2024
Transactions value $
$66,923
Form type
4
Date filed
12/18/2024, 04:53 PM
Previous filing
Dec 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVL Class A Common Stock Options Exercise $5.11K +4.73K +14.2% $1.08 38K Dec 17, 2024 Direct
transaction NUVL Class A Common Stock Options Exercise $61.8K +8.97K +23.59% $6.89 47K Dec 17, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -4.73K -2.35% $0.00 196K Dec 17, 2024 Class A Common Stock 4.73K $1.08 Direct F1
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -8.97K -9.33% $0.00 87.2K Dec 17, 2024 Class A Common Stock 8.97K $6.89 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest as follows: 25% of the shares vested on January 25, 2022 and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
F2 The shares underlying this option vest as follows: 25% of the shares vested on April 29, 2022 and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.